LIVE eSeminars 2024
october
10oct4:00 pm5:00 pmWorld Sight Day - Adult Ocular OncologyJoin this eSeminar with Dr. Jesse L. Berry
Event Details
Course introduction: An overview of adult ocular oncology with a focus on melanoma and the need for yearly dilated exams. Adult ocular oncology is a specialized field addressing the diagnosis and management
Event Details
Course introduction:
An overview of adult ocular oncology with a focus on melanoma and the need for yearly dilated exams.
Adult ocular oncology is a specialized field addressing the diagnosis and management of eye cancers, with ocular melanoma being the most prevalent primary intraocular malignancy in adults. This overview highlights the epidemiology, pathophysiology, and treatment modalities for ocular melanoma, emphasizing its potential for significant morbidity and mortality. Early detection is paramount in improving prognosis and reducing complications. The necessity of yearly dilated eye exams is underscored, given their critical role in the early identification of ocular melanoma and other malignancies. Regular dilated exams allow for comprehensive assessment of the retina and optic nerve, facilitating prompt intervention and improved patient outcomes. This review advocates for increased awareness among healthcare providers and patients about the importance of annual eye examinations in the early detection and management of ocular tumors, ultimately aiming to enhance clinical outcomes and preserve vision.
Learning Objectives:
At the conclusion of this seminar the participants will be able to:
- Identify need for dilated eye exams
- Determine the differential diagnosis for uveal melanoma
- Understand the various treatment mechanisms for uveal melanoma
- Identify long term consequences of radiation therapy
more
Time
(Thursday) 4:00 pm - 5:00 pm
Speakers for this event
-
Dr. Jesse Berry
Dr. Jesse Berry
MD
Jesse L. Berry, MD, is a board-certified ophthalmologist with subspecialty training in ocular oncology. She received her undergraduate and medical degrees from Harvard University in Massachusetts. Following her ophthalmology residency at the University of Southern California, she was the Assistant Chief of Service at the Los Angeles County Medical Center. Dr. Berry completed a fellowship in Ocular Oncology at Children’s Hospital Los Angeles.
Dr. Berry serves as the Vice Chair for Academic Affairs for the Department of Surgery and Director of Ocular Oncology at the Vision Center, CHLA. She actively treats patients with retinoblastoma, uveal melanoma, intraocular and ocular surface tumors. She is active academically within the broader field of ophthalmology and ocular oncology. She is the Vice President of the International Society of Ocular Oncology and was the conference chair for the biennial meeting in Los Angeles 2019. She is an active advocate for mentorship and opportunities for young ophthalmologists. As such, she is a member of the Young Ophthalmologist Committee through the American Academy of Ophthalmology and co-leads the committee for young ophthalmic oncologists and pathologists (YOOPs). Dr. Berry is active within the Women in Ophthalmology organization and founded WOO, Women in Ocular Oncology.
As a physician-scientist, Dr. Berry studies outcomes for retinoblastoma, melanoma and other tumors. Her main interest is the development of aqueous humor as a liquid biopsy for retinoblastoma and other intraocular disease. She was awarded a K08 from the National Cancer Institute of the National Institute of Health in 2018 to study this further.
In 2019, she was promoted to Associate Professor of Ophthalmology and Clinical Scholar, a special distinction provided by USC. In 2021, she was awarded the prestigious USC Faculty Mentoring Award. She currently holds the USC Berle & Lucy Adams Chair in Cancer Research.
MD